Skip to main content

Table 2 Resistance genes that contribute to spatial patterns within the sub-population where metagenomic analysis was performed

From: Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income setting

Gene

SS (trace)

Pseudo-F

p value

Explained variance (proportion)

Resistance mechanism

OXA-1

66.812

9.953

0.001

0.322

Beta-lactams resistance

mcr-1.9

56.881

7.916

0.004

0.274

Peptide antibiotic resistance

BRP(MBL)

55.229

7.603

0.005

0.266

Beta-lactams resistance

dfrA14

48.845

6.454

0.006

0.235

Diaminopyrimidine resistance

omp38

45.105

5.823

0.011

0.217

Beta-lactams resistance

rmtB

42.099

5.336

0.012

0.203

Aminoglycosides resistance

NDM-7

40.965

5.157

0.016

0.197

Beta-lactams resistance

catB3

40.085

5.020

0.014

0.193

Phenicol resistance

vanSG

37.290

4.593

0.024

0.180

Glycopeptide resistance

tsnR

36.330

4.450

0.017

0.175

Peptide antibiotic resistance

mgtA

36.330

4.450

0.015

0.175

Macrolide resistance

mdfA

36.019

4.404

0.023

0.173

Multidrug efflux pump

kpnF

32.752

3.930

0.037

0.158

Multidrug efflux pump

vanN

32.473

3.890

0.041

0.156

Glycopeptide resistance

vanO

31.383

3.736

0.048

0.151

Glycopeptide resistance

CRP

31.383

3.736

0.049

0.151

Multidrug efflux pump

vgaE

31.383

3.736

0.048

0.151

Streptogramin resistance

fusB

31.309

3.726

0.039

0.151

Fusidic acid resistance

cfxA6

30.898

3.668

0.046

0.149

Beta-lactams resistance

  1. Performed using DISTLM test
  2. SS sum of squares